Cabozantinib-associated acquired perforating dermatosis

Denis Smirnov; Hillary Tsibris

doi:10.1016/j.jdcr.2024.06.002

Cabozantinib-associated acquired perforating dermatosis

JAAD Case Rep. 2024 Jun 14:52:38-41. doi: 10.1016/j.jdcr.2024.06.002. eCollection 2024 Oct.

Authors

Denis Smirnov¹, Hillary Tsibris^{2

3}

Affiliations

¹ Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
³ Center for Melanoma Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

No abstract available

Keywords: acquired perforating dermatosis; cabozantinib; elastosis perforans serpiginosa; multikinase inhibitor; perforating disorder; tyrosine kinase inhibitor.

Publication types

Case Reports